Literature DB >> 1587202

Neuroleptic malignant syndrome induced by domperidone.

M J Spirt1, W Chan, M Thieberg, D B Sachar.   

Abstract

A 47-year-old woman with diabetic gastroparesis, on treatment with domperidone, a dopamine-receptor antagonist, was admitted to the hospital in coma, with high blood pressure and nonreactive pupils. She then developed high fever. Her condition progressively worsened for two days, when muscle rigidity was noted and creatine phosphokinase was greater than 2000 U/liter. A diagnosis of neuroleptic malignant syndrome was made, and the patient was given dantrolene with prompt and complete resolution of all signs and symptoms. Subsequent inquiry revealed a distant past history of positive muscle biopsy for malignant hyperthermia, obtained after the diagnosis had been made in a family member. This case suggests that domperidone may induce neuroleptic malignant syndrome and that patients with malignant hyperthermia are at increased risk for this complication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587202     DOI: 10.1007/bf01300396

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Tardive dyskinesia associated with high-dose intravenous metoclopramide.

Authors:  W Breitbart
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

Review 2.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

3.  Neuroleptic malignant syndrome: response to dantrolene sodium.

Authors:  D C May; S W Morris; R M Stewart; B J Fenton; F A Gaffney
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

4.  Neuroleptic malignant syndrome associated with metoclopramide.

Authors:  M B Robinson; R P Kennett; A E Harding; N J Legg; B Clarke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

Review 5.  Mortality from neuroleptic malignant syndrome.

Authors:  A Shalev; H Hermesh; H Munitz
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

6.  Malignant hyperthermia susceptibility in neuroleptic malignant syndrome.

Authors:  S N Caroff; H Rosenberg; J E Fletcher; T D Heiman-Patterson; S C Mann
Journal:  Anesthesiology       Date:  1987-07       Impact factor: 7.892

7.  Metoclopramide-induced neuroleptic malignant syndrome.

Authors:  L S Friedman; L A Weinrauch; J A D'Elia
Journal:  Arch Intern Med       Date:  1987-08

Review 8.  Neuroleptic malignant syndrome.

Authors:  M P Rampertaap
Journal:  South Med J       Date:  1986-03       Impact factor: 0.954

9.  Neuroleptic malignant syndrome in a patient with acquired immunodeficiency syndrome.

Authors:  W B Bernstein; B Scherokman
Journal:  Acta Neurol Scand       Date:  1986-06       Impact factor: 3.209

10.  Neuroleptic malignant syndrome: three episodes with different drugs.

Authors:  C J Lavie; H O Ventura; G Walker
Journal:  South Med J       Date:  1986-12       Impact factor: 0.954

View more
  7 in total

1.  Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.

Authors:  Jessica Grundey; Rosa Amu; Géza Gergely Ambrus; Georgi Batsikadze; Walter Paulus; Michael A Nitsche
Journal:  Psychopharmacology (Berl)       Date:  2015-02-27       Impact factor: 4.530

2.  Domperidone toxicity in an infant on maintenance haemodialysis.

Authors:  Sudarsana De; Christopher Mark Taylor
Journal:  Pediatr Nephrol       Date:  2006-09-08       Impact factor: 3.714

3.  A case of neuroleptic malignant syndrome in an infant.

Authors:  Lalitha Kailas; Sheeja Sugunan; G S Bindu; Christy Cathreen Thomas
Journal:  Indian J Pediatr       Date:  2014-02-01       Impact factor: 1.967

Review 4.  Prokinetics in diabetic gastroparesis.

Authors:  Reza A Hejazi; Richard W McCallum; Irene Sarosiek
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 5.  Antiparkinsonian agents. Drug interactions of clinical significance.

Authors:  R F Pfeiffer
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

6.  Cortical excitability in smoking and not smoking individuals with and without nicotine.

Authors:  J Grundey; S Freznosa; F Klinker; N Lang; W Paulus; M A Nitsche
Journal:  Psychopharmacology (Berl)       Date:  2013-05-05       Impact factor: 4.530

7.  Enteric Fever: Diagnostic Dilemma Encountered in Domperidone-Induced Neuroleptic Malignant Syndrome.

Authors:  Hawwa A Akhunzada; Hassan Rehman; Nabeel Tariq; Mohammad Ali Arif; Rauf Niazi
Journal:  Cureus       Date:  2021-06-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.